1. Home
  2. Stock quotes
  3. CRISPR Therapeutics AG
  4. Financial Ratios
  5. EV/EBITDA Ratio
CRISPR Therapeutics AG logo
CRISPR Therapeutics AG CRSP
$ 40.62 0.57%
mail-toReport an Error

Quarterly report 2024-Q3
added 11-05-2024

report update icon

CRISPR Therapeutics AG EV/EBITDA Ratio 2011-2024 | CRSP

Annual EV/EBITDA Ratio CRISPR Therapeutics AG

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
13.1 -30.4 37.1 -7.01 -23.2 1.46 - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
37.1 -30.4 -1.51